FOLFOX4 versus sequential dose-dense FOLFOX7 followed by FOLFIRI in patients with resectable metastatic colorectal cancer (MIROX): a pragmatic approach to chemotherapy timing with perioperative or postoperative chemotherapy from an open-label, randomized phase III trial

Affiliations

• ¹ Department of Medical Oncology, University Hospital, Lille.
• ² Department of Medical Oncology, Hospital Saint-Antoine, Paris.
• ³ Department of Radiotherapy, Institute Sainte-Catherine, Avignon.
• ⁴ Department of Medical Oncology and Radiotherapy, Hospital Saint-André, Bordeaux.
• ⁵ Department of Oncology, Institute Mutualiste Montsouris, Paris.
• ⁶ Department of Medical Oncology, Radiotherapy Service, Hospital Centre Beauvais, Beauvais.
• ⁷ Regional Centre against Cancer, Val d'Aurelle-Paul Lamarque, Montpellier.
• ⁸ Department of Hepatology and Gastroenterology, Hospital de Haut-Lévêque, Pessac.
• ⁹ Department of Medical Oncology, Hospital Foch, Suresnes.
• ¹⁰ Department of Gastroenterology, Hospital La Roche-sur-Yon, La Roche-sur-Yon.
• ¹¹ Department of Medicine, Hospital Libourne, Libourne.
• ¹² GERCOR, Paris.
• ¹³ Department of Medical Oncology, Hospital Tenon, Paris.
• ¹⁴ Department of Digestive Surgery and Transplantation, University Hospital, Lille.
• ¹⁵ Methodology and Quality of Life in Oncology Department EA 3181, Hospital Besançon, Besançon.
• ¹⁶ Department of Surgery, Institute Mutualiste Montsouris, Paris.
• ¹⁷ Department of Digestive Surgery, Hospital Saint-Antoine, Paris, France.